The Impact of Cereal Grain Composition on the Health and Disease Outcomes
Mattia Garutti(Centro di Riferimento Oncologico), Fabio Puglisi(University of Udine)
Cited by 108
Related Papers
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
|Journal of Clinical Oncology|2010|887
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
|Frontiers in Oncology|2018|205